Travere Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 127.2M | 129.7M | 164.9M | 114.4M | 81.7M | 74.8M | 62.9M | 54.1M |
| Cost of Goods Sold | 26.8M | 2.6M | 1.6M | 1.5M | 4.7M | 2.6M | 1.6M | 12.4M |
| Gross Profit | 100.4M | 127.1M | 163.3M | 112.9M | 77.1M | 72.2M | 61.3M | 41.7M |
| R&D Expenses | 57.1M | 57.9M | 51.9M | 49.4M | 46.9M | 62.1M | 51.7M | 54.3M |
| Operating Expenses | 137.3M | 159.6M | 138.3M | 125.6M | 119.7M | 133.0M | 117.4M | 108.8M |
| Operating Income | -36.9M | -32.4M | 24.9M | -12.7M | -42.7M | -60.7M | -56.1M | -67.1M |
| Other Income / Gains | 193K | 11.4M | 783K | -85K | 1.5M | 397K | 1.3M | -2.5M |
| Net Income | -37.1M | 2.7M | 25.7M | -12.8M | -41.2M | -60.3M | -54.8M | -70.4M |
| EPS (Diluted) | -0.40 | -0.24 | 0.29 | -0.14 | -0.47 | -0.73 | -0.70 | -0.91 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.79 | 0.98 | 0.99 | 0.987 | 0.943 | 0.966 | 0.974 | 0.771 |
| General And Administrative Expenses | 0 | 101.7M | 86.5M | 76.2M | 72.8M | 69.5M | 65.6M | 64.8M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.3M |
| Selling General And Administrative Expenses | 80.3M | 101.7M | 86.5M | 76.2M | 72.8M | 69.5M | 65.6M | 54.4M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 1.4M | 123K | 0 |
| Cost And Expenses | 164.1M | 162.1M | 139.9M | 127.1M | 124.4M | 135.5M | 119.0M | 121.2M |
| Interest Income | 2.6M | 2.6M | 3.0M | 3.3M | 3.8M | 3.8M | 3.6M | 4.4M |
| Interest Expense | 2.3M | 2.3M | 2.8M | 2.8M | 2.9M | 2.8M | 2.8M | 2.8M |
| Depreciation And Amortization | 25.2M | 18.1M | 15.8M | 14.0M | 12.8M | 12.1M | 11.2M | 10.3M |
| Ebitda | -9.2M | -632K | 44.3M | 4.1M | -25.5M | -45.4M | -40.8M | -56.4M |
| Ebitdaratio | -0.072 | -0.005 | 0.268 | 0.036 | -0.312 | -0.607 | -0.649 | -1.043 |
| Operating Income Ratio | -0.29 | -0.25 | 0.151 | -0.111 | -0.522 | -0.812 | -0.893 | -1.239 |
| Income Before Tax | -36.7M | -21.1M | 25.7M | -12.7M | -41.2M | -60.3M | -54.8M | -69.6M |
| Income Before Tax Ratio | -0.289 | -0.162 | 0.156 | -0.111 | -0.504 | -0.807 | -0.872 | -1.286 |
| Income Tax Expense | -120K | 921K | 8K | 20K | 39K | -72K | -84K | 85K |
| Net Income Ratio | -0.292 | 0.021 | 0.156 | -0.111 | -0.504 | -0.806 | -0.871 | -1.301 |
| Epsdiluted | -0.40 | -0.24 | 0.25 | -0.14 | -0.47 | -0.73 | -0.70 | -0.91 |
| Weighted Average Shs Out | 91.9M | 90.3M | 89.2M | 88.9M | 88.4M | 83.1M | 77.8M | 77.5M |
| Weighted Average Shs Out Dil | 91.9M | 90.3M | 102.6M | 88.9M | 88.4M | 83.1M | 77.8M | 77.5M |